INS and Visual impairment: Weibull analysis confirmed an early-onset pattern (early failure model) for all three insulins, with insulin degludec showing the shortest median time-to-onset (23.6 days).<h4>Conclusions</h4>Long-acting insulins are associated with varying risks of visual impairment AEs, exhibiting an early-onset temporal pattern.